ABSTRACT
Objective
This research aimed to evaluate the impact of grading and zoning nursing management on traumatic brain injury (TBI) patients’ emergency treatment outcomes.
Methods
This randomized controlled trial included 200 TBI patients. They were treated with a conventional care (control group, n = 100) and a novel grading and zoning approach (study group, n = 100), respectively. This innovative model organized care into levels based on urgency and complexity, facilitating targeted medical response and resource allocation. Key metrics compared included demographic profiles, consultation efficiency (time metrics and emergency treatment rates), physiological parameters (HR, RR, MAP, SpO2, RBS), and patient outcomes (hospital and ICU stays, complication rates, and emergency outcomes).
Results
The study group demonstrated significantly improved consultation efficiency, with reduced times for physician visits, examinations, emergency stays, and specialist referrals (all p < 0.001), alongside a higher emergency treatment rate (93% vs. 79%, p = 0.004), notably better physiological stability, improved HR, RR, MAP, SpO2 and RBS (p < 0.001), shorter hospital and ICU stays, fewer complications, and superior emergency outcomes.
Conclusion
Grading and zoning nursing management substantially enhances TBI patients’ emergency care efficiency and clinical outcomes, suggesting a viable model for improving emergency treatment protocols.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Data availability statement
The data used to support the findings of this study are available from the corresponding author upon request.
Author contribution
YG conceptualized and designed the study, drafted the initial manuscript. SM, HY, XL and LD collected the data and carried out the initial analyses. JZ critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Ethics approval
This clinical trial complied with the Declaration of Helsinki and was approved by the ethics committee of Affiliated Hospital of Jiangnan University. The patients and their families signed the informed consent form.